Respiratory medications and the risk of cardiac arrhythmias
C Huerta, SF Lanes, LAG Rodríguez - Epidemiology, 2005 - journals.lww.com
Background: Medications used to treat respiratory diseases include beta-adrenoceptors,
antimuscarinics, inhaled and oral corticosteroids, and theophyllines. Most of these drugs …
antimuscarinics, inhaled and oral corticosteroids, and theophyllines. Most of these drugs …
Electrocardiographic abnormalities and cardiac arrhythmias in chronic obstructive pulmonary disease
CA Goudis, AK Konstantinidis, IV Ntalas… - International journal of …, 2015 - Elsevier
Chronic obstructive pulmonary disease (COPD) is independently associated with an
increased burden of cardiovascular disease. Besides coronary artery disease (CAD) and …
increased burden of cardiovascular disease. Besides coronary artery disease (CAD) and …
The cardiopulmonary continuum systemic inflammation as 'common soil'of heart and lung disease
Coronary artery disease (CAD), chronic heart failure (CHF) or chronic obstructive pulmonary
disease (COPD) occur commonly in the presence of each other and are associated with …
disease (COPD) occur commonly in the presence of each other and are associated with …
Bronchodilators: current and future
M Cazzola, MG Matera - Clinics in Chest Medicine, 2014 - chestmed.theclinics.com
The use of bronchodilators is one of the key elements in the treatment of chronic obstructive
pulmonary disease (COPD), although there is often limited reversibility of airflow obstruction …
pulmonary disease (COPD), although there is often limited reversibility of airflow obstruction …
Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing
P Gupta, MS O'Mahony - Drugs & aging, 2008 - Springer
Asthma and chronic obstructive pulmonary disease (COPD) are common disorders that are
associated with increasing morbidity and mortality in older people. Bronchodilators are used …
associated with increasing morbidity and mortality in older people. Bronchodilators are used …
[HTML][HTML] β-agonist intrinsic efficacy: measurement and clinical significance
NA Hanania, A Sharafkhaneh, R Barber… - American journal of …, 2002 - atsjournals.org
Section of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of
Medicine and the Houston Veterans Administration Medical Center; and Department of …
Medicine and the Houston Veterans Administration Medical Center; and Department of …
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2 …
JP Hanrahan, DR Grogan, RA Baumgartner, A Wilson… - Medicine, 2008 - journals.lww.com
Beta-adrenergic stimulation may increase heart rate and the potential for cardiac
arrhythmias. The effect of inhaled long-acting beta2-agonists (LABAs) on these outcomes …
arrhythmias. The effect of inhaled long-acting beta2-agonists (LABAs) on these outcomes …
Cardiovascular safety of salmeterol in COPD
GT Ferguson, C Funck-Brentano, T Fischer, P Darken… - Chest, 2003 - Elsevier
Background Patients with COPD have an increased risk of cardiovascular disease. Despite
the clinical benefits of long-acting β-agonist agents in the treatment of COPD, patients may …
the clinical benefits of long-acting β-agonist agents in the treatment of COPD, patients may …
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
M Cazzola, P Rogliani, J Ora… - … in Chronic Disease, 2023 - journals.sagepub.com
Chronic airway diseases (CAD), mainly asthma and chronic obstructive pulmonary disease
(COPD), are frequently associated with different comorbidities. Among them, cardiovascular …
(COPD), are frequently associated with different comorbidities. Among them, cardiovascular …
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
M Metra, V Zaca, G Parati, P Agostoni… - Journal of …, 2011 - journals.lww.com
A broad spectrum of concomitant disorders may complicate heart failure adding further
morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and …
morbidity and mortality risk. Comorbidities may be subdivided into cardiovascular and …